Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
50
RGEN.CX Quote, Financials, Valuation and Earnings
Last price:
$0.04
Seasonality move
:
26.96%
Day range:
$0.04 - $0.04
52-week range:
$0.02 - $0.09
Dividend yield:
0%
P/E ratio:
0.90x
P/S ratio:
10.94x
P/B ratio:
0.70x
Volume:
--
Avg. volume:
30.4K
1-year change:
--
Market cap:
$5.1M
Revenue:
$45.6K
EPS (TTM):
$0.04
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Regenera Insights, Inc. has -- downside to fair value with a price target of -- per share.
RGEN.CX vs. S&P 500
-
Over the past 5 trading days, Regenera Insights, Inc. has overperformed the S&P 500 by 0.78% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Regenera Insights, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Regenera Insights, Inc. revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter Regenera Insights, Inc. reported revenues of --.
Earnings Growth
-
Regenera Insights, Inc. has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Regenera Insights, Inc. reported earnings per share of -$0.00.
Enterprise value:
4.9M
EV / Invested capital:
0.67x
Price / LTM sales:
10.94x
EV / EBIT:
--
EV / Revenue:
12.34x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
-8.17x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$222.4K
Return On Assets:
118.99%
Net Income Margin (TTM):
--
Return On Equity:
144.61%
Return On Invested Capital:
133.98%
Operating Margin:
-62.56%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.7M | $126.7K | -- | -- | -- | |
| Gross Profit | $6K | -$469.1K | -$222.4K | -$80.7K | -$30.8K | |
| Operating Income | -$2.2M | -$982K | -$375.4K | -$103.3K | -$44.4K | |
| EBITDA | -$1.9M | -$871.4K | -$328.8K | -$92.7K | -$33.7K | |
| Diluted EPS | -$0.04 | -$0.03 | $0.04 | -$0.00 | -$0.00 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.3M | $2.5M | $760.9K | $797.9K | $264.5K | |
| Total Assets | $8.3M | $5.7M | $3.9M | $3.2M | $7.4M | |
| Current Liabilities | $99.6K | $330.2K | $325.5K | $728.1K | $93.2K | |
| Total Liabilities | $152.6K | $334.5K | $375.1K | $1.4M | $101.6K | |
| Total Equity | $8.2M | $5.4M | $3.6M | $1.8M | $7.3M | |
| Total Debt | $64.9K | $16.7K | $66.2K | $787K | $10.2K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$1.7M | -$1.8M | -$595.6K | -$367.7K | -$11.5K | |
| Cash From Investing | $1.1M | -$60.9K | $5.6K | -$300 | -- | |
| Cash From Financing | $316K | $1.8M | $773.8K | $374.2K | $211.5K | |
| Free Cash Flow | -$1.8M | -$1.8M | -$596.5K | -$367.7K | -$11.5K | |
RGEN.CX
Sector
Market Cap
$5.1M
--
Price % of 52-Week High
44.44%
--
Dividend Yield
0%
--
Shareholder Yield
-5.51%
--
1-Year Price Total Return
-57.14%
--
Beta (5-Year)
--
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.04
200-day SMA
Buy
Level
$0.03
Bollinger Bands (100)
Buy
Level
0.02 - 0.04
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$0.04
Relative Strength Index (RSI14)
Buy
Level
50.31
ADX Line
Neutral
Level
Williams %R
Sell
Level
0
50-day SMA
Sell
Level
$0.04
MACD (12, 26)
Sell
Level
0.01
25-day Aroon Oscillator
Sell
Level
-24
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-7.2533)
Sell
CA Score
(Annual)
Level (-1.5127)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (6.3224)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Regenera Insights, Inc. engages in the provision of Environmental Social Governance (ESG) solutions. It products include CO2 capture and utilization, Delta liquids reclamation system, Blue Hydrogen, and Carbon Rx. The company was founded on December 22, 2020 and is headquartered in Regina, Canada.
Stock Forecast FAQ
In the current month, RGEN.CX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RGEN.CX average analyst price target in the past 3 months is --.
-
Where Will Regenera Insights, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Regenera Insights, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Regenera Insights, Inc.?
Analysts are divided on their view about Regenera Insights, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Regenera Insights, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is Regenera Insights, Inc.'s Price Target?
The price target for Regenera Insights, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is RGEN.CX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Regenera Insights, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of RGEN.CX?
You can purchase shares of Regenera Insights, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Regenera Insights, Inc. shares.
-
What Is The Regenera Insights, Inc. Share Price Today?
Regenera Insights, Inc. was last trading at $0.04 per share. This represents the most recent stock quote for Regenera Insights, Inc.. Yesterday, Regenera Insights, Inc. closed at $0.04 per share.
-
How To Buy Regenera Insights, Inc. Stock Online?
In order to purchase Regenera Insights, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get RGEN.CX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RGEN.CX
Sector
P/E ratio
0.90x
--
PEG ratio
-0.01x
--
P/B ratio
0.70x
--
Price / LTM sales
10.94x
--
Growth Metrics
RGEN.CX
Sector
Revenue growth
41.88%
--
Earnings growth
86.36%
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
RGEN.CX
Sector
Profitability FY 2024
-$996.4K
--
Return on invested capital
133.98%
--
Return on assets
118.99%
--
Return on equity
144.61%
--
Earnings Date
Last Earnings Date
Dec
20
Next Earnings Date
Dec
20
Estimated Next Earnings Date
Mar
21
Balance Sheet
RGEN.CX
Sector
Total cash
$211.9K
--
Short term investments
--
--
Total assets
$2.4M
--
Long term debt
$10.2K
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
55
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
35
SMX alert for Dec 19
SMX (Security Matters) Plc [SMX] is up 11.91% over the past day.
Sell
36
INSP alert for Dec 19
Inspire Medical Systems, Inc. [INSP] is up 1.39% over the past day.
Sell
40
INSM alert for Dec 19
Insmed, Inc. [INSM] is up 4.79% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
